About BreathPharma

Science that matters. Written for everyone.


BreathPharma is a science communication platform built at the intersection of pharmaceutical research, cancer pharmacology, and real-world advocacy.

We write for patients navigating difficult diagnoses, students finding their footing in research, and anyone who wants to understand how the medicines of tomorrow are being built today. We also write honestly about the PhD experience.


Our Mission

To educate, advocate, and bridge the gap between cutting-edge pharmaceutical science and the people who need it most.

We translate evidence from peer-reviewed literature into clear, well-cited content — covering cancer pharmacology, drug discovery, epigenetics, cell signalling, and the science behind treatments that are changing lives. We also create space for conversations about what it actually means to pursue a PhD: the pressure, the uncertainty, the small wins, and the resilience it demands.


Our Core Values

Scientific Integrity

Every article on BreathPharma is grounded in peer-reviewed literature and fully cited.

Advocacy Through Knowledge

We believe informed communities make better decisions. By making cancer pharmacology and drug science accessible, we empower patients, caregivers, and advocates to engage meaningfully with their own healthcare and the systems around it.

Honesty About the PhD Experience

We talk about research the way researchers actually experience it — including the stress, the isolation, the imposter syndrome, and the moments that make it all worth it. For students and early-career scientists, knowing that the struggle is real — and survivable — matters as much as the science itself.

Quality Content

We publish fewer articles so we can publish better ones. Every piece is written by a domain expert, reviewed before publication, and held to a standard we are proud to put our names on. We are not chasing clicks — we are building something worth reading.


Want to know who is behind BreathPharma? Meet the team writing and editing every article.